OTC Watch

All stocks / AVAI

AVAI BIO, INC. AVAI

AVAI BIO (AVAI): a late 10-K notice in June 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated floatLate filing OTCQBNevada, USA
Live quote on OTC Markets

Market listing

Full name
AVAI BIO INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 16
Website
ir.avanttechnologies.com/
Source: Stockwatch, 2026-11-17

News headlines

Avai Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery
2026-10-28 08:45 · News Release
Avai Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
2026-10-07 08:45 · News Release
Avai Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
2026-09-30 08:45 · News Release
Avai Bio and Austrianova Present Encapsulated Cell Approach to Sustained alpha-Klotho Delivery at 2026 Klotho Conference
2026-09-24 08:45 · News Release
Avai Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for alpha-Klotho Anti-Aging Therapy
2026-09-15 08:45 · News Release
Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
2026-09-08 09:00 · News Release
Avai Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
2026-08-12 08:30 · News Release
Avai Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy
2026-07-21 08:00 · News Release
Avai Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy
2026-05-20 08:45 · News Release
Five Under-the-Radar Stocks With Catalysts Already in Motion - Across AI Defense, Space, Longevity, Gold, and Post-Quantum Security
2026-04-23 12:00 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2026-03-31
The report says
Net loss
($1,749,509)
What it means

It spends more than it earns

Under strain

The company lost $1.7 million in the year. It reported no sales.

The report says
Cash and cash equivalents
$23,145
Net cash used in operating activities
($1,009,844)
What it means

The cash could run out soon

Under strain

It had $23,145 in the bank and used about $84,154 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$572,696
Total liabilities
$3,387,851
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $572,696. Its debts and unpaid bills add up to $3.4 million. That is about $5.92 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-13

Estimated float about 154,872,536 shares as of 2026-11-13: 154,872,536 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-06-30

Filed NT 10-K on 2026-06-30: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-12-31
138.0M
2026-02-12
138.3M
2026-03-31
153.2M
2026-06-30
153.9M
2026-07-14
153.9M
2026-08-13
153.9M
2026-09-30
154.4M
2026-11-13
154.9M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-13 10-QREPORT 10-Q
2026-08-13 10-QREPORT 10-Q
2026-07-14 10-KREPORT 10-K
2026-06-30 NT 10-KNOTIFICATION OF LATE FILING
2026-05-08 8-KFORM 8-K
2026-02-12 10-QREPORT 10-Q
2026-02-09 8-K8-K

Common questions about AVAI

Does AVAI file reports with the SEC?

Yes. AVAI BIO files with the SEC under company number 0001740797. The most recent filing we hold is a 10-Q dated 2026-11-13.

Source record

How many AVAI shares are outstanding?

154,872,536 shares as of 2026-11-13, as reported to the SEC.

Source record

Has AVAI filed reports late?

Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-K on 2026-06-30. A notice means a report was not ready on time; check whether the report followed.

Source record

Is AVAI BIO making money?

The company lost $1.7 million in the year. It reported no sales. (Annual figures to 2026-03-31. Facts from the company's own report, not a recommendation.)

Source record